SCYNEXIS Inc (SCYX) stock
SCYXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 13/3072% below fair value
$2.85−0.06 (-2.06%)
Close on Nov 17, 2026Market cap $28.36MP/E –Yield –
Scynexis cash
Cash and short-term investments held at the end of each period.
Scynexis's cash was $71.10M at Jun 30, 2026. For fiscal 2025 it was $56.30M, down 25.0% from the year before. Over ten years it grew 1.8% a year on average. The highest annual figure on record is $104.70M in fiscal 2021.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $56.30M | -25.0% |
| FY2024 | Dec 31, 2024 | $75.10M | -23.4% |
| FY2023 | Dec 31, 2023 | $98.00M | +33.3% |
| FY2022 | Dec 31, 2022 | $73.50M | -29.8% |
| FY2021 | Dec 31, 2021 | $104.70M | +12.2% |
| FY2020 | Dec 31, 2020 | $93.31M | +121.2% |
| FY2019 | Dec 31, 2019 | $42.19M | +258.6% |
| FY2018 | Dec 31, 2018 | $11.77M | +2.6% |
| FY2017 | Dec 31, 2017 | $11.47M | -80.4% |
| FY2016 | Dec 31, 2016 | $58.59M | +24.7% |
| FY2015 | Dec 31, 2015 | $46.99M | +45.7% |
| FY2014 | Dec 31, 2014 | $32.24M | +2199.8% |
| FY2013 | Dec 31, 2013 | $1.40M | -41.2% |
| FY2012 | Dec 31, 2012 | $2.39M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $71.10M | +52.9% |
| Q1 FY2026 | Mar 31, 2026 | $72.40M | +34.6% |
| Q4 FY2025 | Dec 31, 2025 | $56.30M | -25.0% |
| Q3 FY2025 | Sep 30, 2025 | $37.90M | -55.4% |
| Q2 FY2025 | Jun 30, 2025 | $46.50M | -44.4% |
| Q1 FY2025 | Mar 31, 2025 | $53.80M | -42.9% |
| Q4 FY2024 | Dec 31, 2024 | $75.10M | -23.4% |
| Q3 FY2024 | Sep 30, 2024 | $84.90M | -19.3% |
| Q2 FY2024 | Jun 30, 2024 | $83.70M | -8.9% |
| Q1 FY2024 | Mar 31, 2024 | $94.20M | +71.9% |
| Q4 FY2023 | Dec 31, 2023 | $98.00M | +33.3% |
| Q3 FY2023 | Sep 30, 2023 | $105.20M | +9.5% |
| Q2 FY2023 | Jun 30, 2023 | $91.90M | -22.7% |
| Q1 FY2023 | Mar 31, 2023 | $54.80M | -42.6% |
| Q4 FY2022 | Dec 31, 2022 | $73.50M | -29.8% |
| Q3 FY2022 | Sep 30, 2022 | $96.10M | -4.2% |
| Q2 FY2022 | Jun 30, 2022 | $118.91M | +5.5% |
| Q1 FY2022 | Mar 31, 2022 | $95.43M | +3.4% |
| Q4 FY2021 | Dec 31, 2021 | $104.70M | +12.2% |
| Q3 FY2021 | Sep 30, 2021 | $100.33M | +237.0% |
| Q2 FY2021 | Jun 30, 2021 | $112.72M | +228.7% |
| Q1 FY2021 | Mar 31, 2021 | $92.28M | +349.6% |
| Q4 FY2020 | Dec 31, 2020 | $93.31M | +121.2% |
| Q3 FY2020 | Sep 30, 2020 | $29.77M | +150.3% |
| Q2 FY2020 | Jun 30, 2020 | $34.29M | +76.1% |
| Q1 FY2020 | Mar 31, 2020 | $20.53M | +54.6% |
| Q4 FY2019 | Dec 31, 2019 | $42.19M | +258.6% |
| Q3 FY2019 | Sep 30, 2019 | $11.89M | -27.5% |
| Q2 FY2019 | Jun 30, 2019 | $19.48M | +174.5% |
| Q1 FY2019 | Mar 31, 2019 | $13.28M | -51.8% |
| Q4 FY2018 | Dec 31, 2018 | $11.77M | +2.6% |
| Q3 FY2018 | Sep 30, 2018 | $16.41M | +87.5% |
| Q2 FY2018 | Jun 30, 2018 | $7.10M | -4.7% |
| Q1 FY2018 | Mar 31, 2018 | $27.55M | -49.8% |
| Q4 FY2017 | Dec 31, 2017 | $11.47M | -80.4% |
| Q3 FY2017 | Sep 30, 2017 | $8.75M | -70.6% |
| Q2 FY2017 | Jun 30, 2017 | $7.45M | – |
| Q1 FY2017 | Mar 31, 2017 | $54.90M | – |
| Q4 FY2016 | Dec 31, 2016 | $58.59M | – |
| Q3 FY2016 | Sep 30, 2016 | $29.81M | – |
See a number that looks wrong?